Author

Bin Zheng

Observed name: Bin Bin Zheng

Institutions: Shanxi Medical University, Wenzhou Institute, University of Chinese Academy of Sciences

Observed institutions: Shanxi Medical University, Huzhou Normal University, Bristol-Myers Squibb (United States), Wenzhou Institute, University of Chinese Academy of Sciences

ORCID: 0000-0002-4719-2391

Observed ORCID: 0000-0002-4719-2391

OpenAlex ID: A5075660960

Process Research and Development for an Efficient Synthesis of the HIV Protease Inhibitor BMS-232632

2002 · Zhongmin Xu, Janak Singh, et al. · Organic Process Research & Development · 67

Auto-Induction of Intestinal First-Pass Effect Related Time-Dependent Pharmacokinetics of Artemisinin Rather than Dihydroartemisinin

2020 · Liqing Chai, Rongrong Wang, et al. · Journal of Pharmaceutical Sciences · 14

Red Blood Cell Membrane-Camouflaged Reduction-Responsive Polyethylenimine-Based Nanoparticles for Enhanced Antitumor Efficacy of Antisense Oligonucleotides

2025 · Shuang Yang, Beibei He, et al. · Molecular Pharmaceutics · 5

Design and Antimalarial Evaluation of Polydopamine-Modified Methyl Artelinate Nanoparticles

2024 · Qingxia Li, Rongrong Wang, et al. · Molecular Pharmaceutics · 4

Glucose-functionalized redox-responsive dihydroartemisinin prodrug nanosystem for targeted malaria therapy

2025 · Rongrong Wang, Rongrong Wang, et al. · International Journal of Pharmaceutics X · 1

Observing one-step melting pathway in two-dimensional hard circular particle system

2025 · Yanwen Zhu, Shenhua Jiang, et al. · iScience

Efficient Synthesis of 3,4-Dihydropyrimidin-2(1H)-Ketone Using SbCl3 as Catalyst under Ultrasonic Conditions

2013 · Jin Lin, Jing Fen Li, et al. · Applied Mechanics and Materials

Works count: 7

Citation count: 91

H-index: 4

I10-index: 2